Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
31.43
-0.57 (-1.78%)
Oct 1, 2026, 2:53 PM EDT - Market open
Korsana Biosciences Market Cap
Korsana Biosciences has a market cap or net worth of $1.43 billion as of October 1, 2026. Its market cap has increased by 18,547.07% in one year.
Market Cap
1.43B
Enterprise Value
1.30B
1-Year Change
18,547.07%
Ranking
Category
Stock Price
$31.43
ChartMarket Cap Chart
Since March 18, 2019, Korsana Biosciences's market cap has increased from $97.18M to $1.43B, an increase of 1,372.91%. That is a compound annual growth rate of 42.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.43B | 28,612.67% |
| Dec 31, 2025 | 4.99M | -42.87% |
| Dec 31, 2024 | 8.73M | 6.54% |
| Dec 29, 2023 | 8.19M | 473.97% |
| Dec 30, 2022 | 1.43M | -61.69% |
| Dec 31, 2021 | 3.73M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.57B |
| Immunocore Holdings | 1.57B |
| Inhibrx Biosciences | 1.55B |
| Hemab Therapeutics Holdings | 1.55B |
| Maze Therapeutics | 1.51B |
| Innoviva | 1.51B |
| Tyra Biosciences | 1.50B |
| AnaptysBio | 1.50B |